Filing Details
- Accession Number:
- 0001144204-14-066839
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-12 08:03:25
- Reporting Period:
- 2014-11-10
- Filing Date:
- 2014-11-12
- Accepted Time:
- 2014-11-12 08:03:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369868 | China Biologic Products Inc. | CBPO | Biological Products, (No Disgnostic Substances) (2836) | 752308816 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1515939 | Wenfang Liu | C/O Cbpo, 18F, Jialong Int'L Tower, 19 Chaoyang Park Rd. Beijing F4 100125 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-10 | 500 | $17.00 | 7,580 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-11-10 | 500 | $62.75 | 7,080 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-10 | 7,080 | $62.75 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-11-10 | 500 | $0.00 | 500 | $17.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
19,500 | 2011-08-27 | 2021-02-27 | No | 4 | M | Direct |
Footnotes
- Represents 500 shares of common stock (the "Sold Common Stock") sold on the open market for $62.75 per share on November 10, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 2 below for further details on the relevant stock options.
- Represents previously reported stock options to purchase 20,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement dated February 27, 2011, half of which will vest on August 27, 2011, and the remainder of which will vest on February 27, 2012.